Tirzepatide 10mg Peptide Powder - 99.9% Purity for Scientific Research

Tirzepatide, also known as LY3298176, is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It is developed for the treatment of type 2 diabetes and has shown significant efficacy in glucose control and weight loss compared to other treatments.

With a molecular formula of C225H348N48O68 and a purity of 99.9%, tirzepatide 10mg is supplied as a white powder in vials. Each vial contains 10mg of the peptide, and packaging is available in boxes of 10 vials. This product is intended for research use only and is not for personal consumption.

Clinical trials, such as SURMOUNT-1, have demonstrated that tirzepatide leads to substantial weight loss, with average reductions of 15% at 5mg, 19.5% at 10mg, and 20.9% at 15mg doses over 72 weeks. Its dual agonist behavior provides enhanced hyperglycemia reduction, making it a valuable compound for metabolic research.

When handling tirzepatide 10mg, it is essential to store the peptide in a cold, dry, and dark place to maintain stability. Avoid repeated freezing and thawing, overexposure to air, and prolonged storage in solution. Proper aliquoting according to experimental requirements is recommended for optimal results.